Specialty pharmaceutical company Vyome Therapeutics Inc. on Thursday announced that it has raised $22 million in a Series D round of funding led by venture capital firm Iron Pillar.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
